Editorial: Genetic Pleiotropy in Complex Traits and Diseases

Qian Xu, Can Yang, Yu‐Fang PeiFrontiers in Genetics 2022 · DOI · OpenAlex

Abstract

Genetic pleiotropy, the phenomenon of a single gene or a single genetic variant influencing multiple phenotypes, appears to be pervasive in the human genome. Thousands of genome-wide association studies (GWASes) have identified hundreds of thousands of genetic variants associated with hundreds of complex traits or diseases. Identification of pleiotropic effects may help to explain the observations for shared heritability and comorbidity among multiple complex traits and shed light on the underlying biological mechanisms for those traits. However, progress in the identification and understanding of genetic pleiotropic effects remains limited. Indeed, the associations of genetic loci with multiple traits observed in GWAS studies are cross-phenotype associations, which are distinguished from pleiotropic effects.

Introduction

As the field of genomics matures, it has become increasingly clear that the "one gene, one disease" paradigm is the exception rather than the rule. Genetic pleiotropy—where a single genetic variant or locus influences multiple distinct traits—is a fundamental characteristic of human biology. Current estimates suggest that approximately 31% of Single Nucleotide Polymorphisms (SNPs) and 63% of genes identified in GWAS are pleiotropic. This editorial summarizes a collection of eight studies that advance our ability to detect, interpret, and utilize these shared genetic signals to understand complex diseases.

The Challenge of Interpretation

While the pervasiveness of cross-phenotype associations is well-documented, interpreting them remains a significant hurdle. A genetic locus associated with two traits may represent "biological pleiotropy" (independent pathways), but it could also indicate a "mediated" relationship (where Trait A causes Trait B) or a "spurious" association caused by statistical noise or linkage disequilibrium. Furthermore, many traditional multivariate statistical methods require individual-level patient data. Due to privacy concerns and logistical barriers, such data is often inaccessible, creating a demand for robust methods that can operate solely on publicly available GWAS summary statistics.

Methodological Innovations

To address these challenges, several new statistical frameworks and tools have been introduced:

  • The OMNI Test (Omnibus Test): Developed by Liu et al., this procedure utilizes an aggregated Cauchy association test to combine multiple statistical signals (GBJ, GHC, and MinP). It is specifically designed to be robust against varying signal directions and "sparsity," which occurs when only a few variants within a genomic region are functional.
  • Hierarchical Clustering (HCDC): Fu et al. proposed a clustering approach for the joint analysis of multiple phenotypes. By grouping related traits, this method increases the statistical power to uncover novel variants that might remain hidden in single-trait analyses.
  • MultiABEL: This open-source R package, introduced by Ning et al., implements a rigorous four-level replication strategy. This ensures that identified multi-trait associations are statistically credible and reduces the risk of false positives.
  • Mendelian Randomization (MR): Several studies in this collection leveraged MR—a technique using genetic variants as instrumental variables—to distinguish between correlation and true causation in pleiotropic relationships.

Key Insights into Disease Architecture

The application of these methods has yielded significant insights into the shared genetic foundations of diverse conditions:

Autoimmunity and Inflammation

Research into systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) identified 14 shared genes. Notably, four of these genes were previously unknown to be linked to both conditions, suggesting that these clinically distinct autoimmune diseases may share a common biological trigger.

Cardiovascular Health

By analyzing coronary artery disease (CAD), peripheral artery disease, and seven atherosclerosis risk factors in tandem, researchers identified 25 novel pleiotropic loci. This holistic approach provides a more comprehensive map of cardiovascular risk than studying individual conditions in isolation.

Using bi-directional Mendelian Randomization, researchers found evidence of shared genetic risk mechanisms between osteoarthritis (OA) and major depression. This finding provides a potential biological explanation for the high rate of comorbidity observed between chronic physical pain and mental health disorders.

Oncology

The ICAM-1 gene was highlighted as a significant pleiotropic candidate associated with breast, gastric, and cervical cancers in specific populations, marking it as a potential target for cross-cancer diagnostic or therapeutic research.

Limitations and Future Directions

Despite these advancements, the systematic characterization of pleiotropy is still in its early stages. Future research must focus on three key areas:

  1. Refining Causal Inference: Better methods are needed to definitively separate biological pleiotropy from mediated effects.
  2. Integrating Multi-omics: Moving beyond DNA to include proteomics, transcriptomics, and metabolomics will be essential to map the functional pathways from a variant to multiple traits.
  3. Biological Validation: Statistical predictions must be paired with high-throughput laboratory validation to confirm that predicted pleiotropic genes function as expected in cellular and animal models.

In conclusion, recognizing pleiotropy as a central feature of the human genome allows researchers to move toward a more integrated understanding of human health, potentially leading to better risk prediction and the discovery of multi-purpose therapeutic targets.

Summary updated

Abstract

Genetic pleiotropy, the phenomenon of a single gene or a single genetic variant influencing multiple phenotypes, appears to be pervasive in human genome. Thousands of genome-wide association studies (GWASes) have identified hundreds of thousands of genetic variants associated with hundreds of complex traits or diseases. Identification of pleiotropic effects may help to explain the observations for shared heritability and comorbidity among multiple complex traits and shed light on the underlying biological mechanisms for those traits. However, progress in the identification and understanding of genetic pleiotropic effects remains limited. Indeed, the associations of genetic loci with multiple traits observed in GWAS studies are cross-phenotype associations, which are distinguished from pleiotropic effects. Solovieff et al. (
BibTeX
@inproceedings{xu2022editorial,
  author = {Qian Xu and Can Yang and Yu‐Fang Pei},
  title = {{Editorial: Genetic Pleiotropy in Complex Traits and Diseases}},
  booktitle = {Frontiers in Genetics},
  year = {2022},
  doi = {10.3389/fgene.2022.897383},
}
Figure